glycolipid")7' 8 this fraction, which was eventually characterized to be sialyllactosylceramide (hematoside), was separated by preparative thin-layer chromatography. Hematoside was quantitatively determined by the sialic acid contentl4 after being separated on thin-layer chromatography followed by iodine stain and extraction of the spot.
The lower phase was distilled to dryness, dissolved in 0.1 N NaOH in methanol-water (9:1) and saponified at 370 for 6 hr. Two vol of chloroform and '/2 vol of water were added to the reaction mixture and the mixture shaken. The lower layer was again shaken with 1/3 vol of water. The lower layer was evaporated under nitrogen and dried in a desiccator. The dried residue was dissolved in chloroform-methanol (9:1) and put onto a column of Florisil (0.9 X 5 cm) prepared in the same solvent. Elution was carried out with chloroform-methanol mixtures in the ratios: 8:2, 7:3, 6:4, 4:6, and 2:8. Each fraction was analyzed by thin-layer chromatography on silica gel H. Since the third fraction, eluted from the Florisil column with chloroform-methanol (6:4), contained only lactosylceramide, the quantitative determination of this glycolipid was carried out by analysis of the total hexoses of this fraction by cystein-sulfuric acid."5 On the other hand, semiquantitative estimation of the glycolipids on thin-layer chromatography was performed by comparison of the intensities of the spots developed with orcinol-sulfuric acid with known quantities (3-30 ,g) of standard glycolipids. This simple method was found to be highly dependable.
Characterization of glycolipids: The limited amounts of tissue culture cells available yielded only micromolar quantities of the glycolipids. Nevertheless, the main glycolipids have been sufficiently characterized on the bases of: (1) migration rates determined by thin-layer chromatography on silica gel H and on borate-impregnated silica gel H developed with chloroform-methanol-water, 60:35:8, 65:25:4, and chloroform-methanol-2.5 N ammonia, 60:35:8;16 (2) sugar ratio analysis by gas-liquid chromatography of glycolipid fractions obtained from the thin-layer plates;'7 (3) identification of the oligosaccharides by thin-layer chromatography after osmium-periodate and alkaline degradation;"8 and (4) analysis of sphingosin by thin-layer chromatography. '9 Cytoagglutination by wheat germ phytoagglutinin and its inhibition: Wheat germ phytoagglutinin was purified according to the method of Burger and Goldberg.20 Agglutinability of different cell lines was tested according to Aub et al.2' Cells were trypsinized for 2 min and suspensions containing 106 cells per milliliter of phosphate-saline at pH 7.4 was used. Inhibition of the cytoagglutination was tested in the presence of "carrier lipid" as has been described earlier .8 Results.-Characterization of the glycolipids of hamster kidney fibroblast cells: The main glycolipid found in Fr. 1 of the three cell lines of hamster kidney fibroblasts was identified to be a N-acetylneuraminyllactosylceramide, based on the following findings: (1) the glycolipid had a Rf value identical to the "hematoside" of human erythrocytes2" when subjected to thin-layer chromatography on silica gel H; (2) it contained equimolar quantities of glucose, galactose, and sialic acid; (3) hydrolysis in 0.1 N hydrochloric acid at 800 for one hour split the glycolipid into lactosylceramide and N-acetylneuraminic acid; and (4) degradation of the glycolipid as described by Hakomoril8 gave a spot which was coincident with N-acetylneuraminyl (2-..3) galactosyl (1-*4) glucose (product of General Biochemicals, Ohio) but not with N-glycolyl-neuraminyl (2-*o3) galactosyl (1--.4) glucose. 18 The hydrophobic glycolipids which are present in Fr. 2 were investigated after the glycerophosphatides had been eliminated by saponification.23 Only one kind of glycolipid, which was identified as lactosylceramide, was found to be present. No detectable amounts of cerebroside, ceramide trihexoside, or globosides were found in any of the three cell lines. The identification of lactosylceramide was based on the liberation of lactose by the degradation previously described '8 and by the finding that the Rf values of the double spots given by this glycolipid on thin-layer chromatography were identical to those of lactosylceramide isolated from erythrocytes.24
Reciprocal relationship between the quantities of hematoside and lactosylceramide in normal and transformed cell lines: The quantities of hematoside and lactosylceramide present in a cell are found to show a reciprocal relationship depending on whether the cells are derived from the normal or one of the malignant cell lines ( Fig. 1 and Table 1 ). The hematoside content was the highest in the normal fibroblast line (clone 1), followed by that in the spontaneously transformed line (clone 2), and the polyoma virus-transformed cell line (clone 3) contained only one fifth the quantity found in the normal fibroblasts. The quanti- ties of lactosylceramide were found to have a reversed relationship; the level in normal fibroblasts was only one tenth that found in the virus-transformed line and the level of the clone 2 cell line was almost the same as that of the malignant cell line. Agglutinability of normal and malignant-transformed cells by wheat germ phytoagglutinin and the presence of a specific glycolipid in the malignant cells which is capable of inhibiting the malignant cytoagglutination: The malignant cytoagglutination evoked by wheat germ phytoagglutinin was found to be parallel with the malignancy of the cells (Table 2 ). In addition to hematoside and lactosylcera- (Table 3 ). The finding of Burger and Goldberg20 that N-acetylglucosamine is the sole monosaccharide inhibitor of this agglutination system has been confirmed.
The ganglioside fraction of the normal cell line was found to have no inhibitory activity. However, oxidation of the normal ganglioside fraction in aqueous solution with 0.01 it sodium metaperiodate for one hour, followed by sodium borohydride treatment and weak acid hydrolysis (Smith degradations) yielded a product which was found to be capable of inhibiting the malignant cytoagglutination (see Table 3 ). Control experiments with globoside and "tumor glycolipid" indicated that only the nonreducing sugar was degraded under the same condition. Simple acid hydrolysis did not cause any activity changes in the normal gangliosides.
Discussion.-The glycolipids of fibroblasts have not been investigated previously. It has become clear through this study that the main glycolipid of normal hamster fibroblasts is a "hematoside" type of glycolipid, 2 containingN- It is of interest that the hematoside content of fibroblasts was greatly diminished, while that of lactosylceramide, a precursor of the hematoside, was apparently increased after the fibroblasts had been transformed into malignant cells by polyoma virus (Fig. 2) . The cell line (clone 2) whose malignant property was intermediate between the normal and the virus-tranisformed line had an intermediate pattern of glycolipid composition. A fairly good correlation was found between the quantity of hematoside and the contact-inhibitor properties of the three lines of hamster kindey fibroblasts studied. The quantity of lactosylceramide present was in reciprocal proportion to the hematoside. In other words, the more contact-inhibited cells contained more glycolipids with completed carbohydrate chains and a smaller quantity of precursor glycolipid, and vice versa. The larger quantity of lactosylceramide and the smaller quantity of hematoside in the noncontact-inhibited malignant cells could be the result of either incomplete synthesis of hematoside, possibly due to an impaired sialyl transfer mechanism, or enhanced neuraminidase activity. These results contrast to the earlier finding that sialic acids on cell surface of malignant cells were higher than that of normal cells.27 Sialic acids bound to lipid is a small portion of total sialic acid, and the true mechanism which determines the quantity of hematoside and lactosylceramide may be more complex than is simply predicted. Whatever the mechanism is, this finding suggests the occurrence of "incomplete carbohydrate chains" in the glycolipid of malignant cells. The large increase in the concentration of lactosylceramide, following malignant transformation, may be related to the finding by Rapport et al.28 that lactosylceramide ("cytolipin H") is a tumor-specific hapten in many The quantity of the starting cells was identical as 100 mg protein/S ml; Fr. 1 was' dissolved in 0.2 ml, and 20 ;4l was applied. CL fraction was dissolved in 0.2 ml, and 20 ;l was applied.
cases of human tumor. The parallelism in the quantity of hematoside and the contact-inhibitory property of the fibroblast may suggest a certain role for the hematoside in maintaining the "ektobiological" characteristics of the normal fibroblasts. However, one has to be careful in drawing such a conclusion since other glycolipids were also altered by malignant transformation. No evidence was furnished, at the present time, that hematoside and lactosylceramide are located on the cell surfaces.
The agglutinability of the three cell lines by the purified wheat germ phytoagglutinin showed a surprisingly good parallelism between their contact inhibitory properties. The ganglioside fraction of malignant cells could indeed inhibit the malignant cell agglutination but the ganglioside fraction of normal cells was without activity. This again indicates that some structural change of the gangliosides may occur concomitant to the malignant transformation of cells and the appearance of an abnormal ganglioside may closely relate to the change in property of the cell surface. The characterization of such abnormal gangliosides is now in progress.
The conversion of the normal gangliosides with no inhibitory activity to a material which is capable of inhibiting the malignant cytoagglutination by the Smith degradation suggests that the reactive group is masked in the normal ganglioside by a periodate-susceptible group (either galactose or fucose). The removal of such a masking group from the normal ganglioside can transform the normal ganglioside to an abnormal ganglioside which is capable of inhibiting the malignant cytoagglutination. This again suggests the occurrence of an incom-plete carbohydrate chain in the glycolipids of malignant cells. This concept is compatible with the earlier results showing the deletion of blood group A-and B-haptens and the simultaneous accumulation of Lea and H-glycolipids in human adenocarcinoma.8' 9 29 Such a "deletion" or "incompletion" of carbohydrate chains must be a result of either a defect or an inhibition of enzymes participating in metabolism of sugars which are presumably controlled by regulatory genes. Galactose-epimerase "choke" in different malignant cells as illustrated by Kalckar30, 31 is such an example. The alteration in the pattern of sugar metabolism and function of cells in relation to the structural remodeling of glycolipids and glycoproteins are undoubtedly a key to open a secret box of malignancy.
Summary.-The main glycolipid present in the normal hamster kidney fibroblasts (BHK-21,C13) was identified to be N-acetyl-neuraminyllactosylceramide (hematoside), the quantity of which was found to be greatly diminished in the malignant-transformed cells. The second glycolipid, which was characterized to be lactosylceramide, increased in the malignant-transformed cells. A reciprocal relationship between the quantities of hematoside and lactosylceramide present has been noticed to exist depending on the biological properties of the cells.
The cytoagglutination evoked by purified wheat germ agglutinin, characteristic for malignant cells, was specifically inhibited by the ganglioside fraction of malignant cells but not by the same fraction of normal fibroblasts.
